Jingxin Wang

Principle Investigator (since 2019.7)

Scripps Research - La Jolla, USA (Postdoc, 2019, Advisor: Prof. Peter G. Schultz, Co-advisor: Dr. Kristen A.  Johnson)
Johns Hopkins University, USA (Postdoc, 2014, Advisor: Prof. Jun O. Liu)
University of Maryland - College Park, USA (PhD, 2011, Advisor: Prof. Herman O. Sintim)
Peking University, China (BS, 2006, Advisor: Prof. Zhi-xiang Yu)

Zhichao Tang

Postdoctoral Researcher (since 2019.12)

China Pharmaceutical University, China (PhD, 2016)

Junxing Zhao

Postdoctoral Researcher (since 2020.1)

Shanghai Jiaotong University, China (PhD, 2019)

Shalakha Hegde

Graduate Student (since 2021.5)

​

Mercy A. Haboro

Postbaccalaureate Researcher (since 2022.1)

​

Diba Gharavi

Postbaccalaureate Researcher (since 2022.2)

​

Past Group Members

Sadikshya Aryal, Associate Researcher (2020.2-2020.7)
Next step: Purdue University
Ankita Ramprasad, M.S. Graduate Student (2019.12-2021.7)
Manikandan Selvaraju, Postdoc Researcher (2020.7-2021.9)

Biography of Jingxin Wang, Ph.D. 

Jingxin Wang graduated with a B.S. in chemistry in 2006 from Peking University, China, where he performed research in computational chemistry and transition-metal catalysis (advisor: Prof. Zhi-Xiang Yu). He completed his Ph.D. in chemistry in 2011 at the University of Maryland, College Park, under the guidance of Prof. Herman Sintim. He was trained to synthesized novel molecules to combat bacterial antibiotic resistance. After graduation, he joined Prof. Jun Liu’s laboratory as a postdoc at Johns Hopkins University and conducted research on a novel drug modality using small molecules to induce protein-protein interaction. In 2014, he started further chemical biology training in Prof. Peter Schultz's laboratory (co-advised by Dr. Kristen Johnson) at the Scripps Research Institute, where he is performing high-throughput screening, assay development and target validation for novel viral and cancer immunotherapy, as well as mechanistic studies for molecules that interfere with pre-mRNA splicing. He joined KU in 2019 as a tenure-track Assistant Professor. His current research focuses on modulating RNA biochemistry and innate immunity in human cells using small-molecule probes.